W
LLY icon

WorthPointe’s Eli Lilly LLY Stock Holding History

WorthPointe’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
261
+7
+3% +$7.15K 0.08% 93
2026
Q1 		$234K Sell
254
-43
-14% -$43.6K 0.06% 106
2025
Q4 		$319K Buy
+297
New +$284K 0.08% 103
2025
Q2 		– Sell
-420
Closed -$347K – 102
2025
Q1 		$347K Sell
420
-31
-7% -$25.8K 0.16% 66
2024
Q4 		$348K Sell
451
-18
-4% -$14.9K 0.14% 66
2024
Q3 		$416K Buy
469
+204
+77% +$183K 0.17% 55
2024
Q2 		$240K Buy
+265
New +$212K 0.11% 64
2023
Q4 		– Sell
-428
Closed -$230K – 79
2023
Q3 		$230K Buy
+428
New +$221K 0.14% 63

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WorthPointe's LLY Position: Q2 2026 in Review

WorthPointe increased its Eli Lilly (LLY) stake by 2.8% in Q2 2026, buying an estimated $7.15K and bringing the position to 261 shares worth $313K. The position accounts for 0.08% of the portfolio, ranked #93.

WorthPointe first reported a position in LLY in Q3 2023 and has held it in 8 quarters since. The position peaked at $416K in Q3 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • WorthPointe held 261 shares of Eli Lilly worth $313K as of Q2 2026.
  • WorthPointe bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.08% of WorthPointe's portfolio in Q2 2026, its #93 holding.
  • WorthPointe first reported a position in Eli Lilly in Q3 2023 and has held it in 8 quarters since.
  • WorthPointe's Eli Lilly position peaked at $416K in Q3 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on WorthPointe's 13F filing for Q2 2026, filed 31 Jul 2026.